*You are now in the CME section of our website
Sclerotherapy: Cosmetic Telangiectasias of the Lower Extremities
This one day, 8.5 hours CME cosmetic training course will prepare you to offer what is still considered to be the “gold standard” treatment of telangectasias and reticular veins. The first part of the day will address anatomy, physiology as well as the pathophysiology pertaining to leg and facial veins. The most current techniques, sclerosing solutions, safety issues and complications to avoid will be covered. How to set up a sclerotherapy practice is essential to your success and attention will be placed on integrating this treatment into your aesthetic menu of services. Other modalities for vein treatment will also be discussed
The afternoon will be dedicated to the hands-on practice of sclerotherapy treatments by injection. You will learn the principles and pearls of obtaining a comprehensive history and physical exam followed by injecting safely and effectively. Our experienced instructors will work closely with you to build your confidence through practice techniques that have demonstrated success.
Sample Program Agenda
8:00am – 12:00pm
Didactic Lecture on Dermal Fillers and Botulinum Toxins
12:00pm – 12:30pm
12:30pm – 4:45pm
Hands-On Training for Dermal Fillers and Botulinum Toxins with Live Injections
4:45pm – 5:00pm
Review, Discussion, Q&A
These activities are designed to meet the educational needs of physicians, physician assistants, nurse practitioners and registered nurses involved in the care of patients undergoing medical aesthetic procedures.
This CME cosmetic training course will teach the principles and techniques that the clinician will need for successful cosmetic sclerotherapy treatments.
1. Identify the primary anatomy of the lower extremity venous system
2. Describe proper evaluation and assessment of treatment options for cosmetic telangiectasia
3. Review patient education, including pre- and post- procedure instructions and healthy leg principles
4. Explain sclerosants and their appropriate use
5. List potential complications associated with injection sclerotherapy
6. Demonstrate effective injection techniques
7. Describe components of a successful sclerotherapy practice
Physician Credit Designation
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category I Credit(s)™ from organizations accredited by ACCME.
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 8.5 contact hours.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education.
Provider Number: 030803.
This activity is awarded 8.5 contact hours which includes 0 hours of pharmacology. Program ID #21524.
There is no commercial support for this activity
It is the policy of AKH Inc. and AAI to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
AKH Inc. and AAI planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
*Program subject to change.